Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 12
Submit an article Journal homepage
29
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Role of Liposomal Daunorubicin, Fludarabine and Cytarabine (FLAD) in the Salvage Therapy of Adult Acute Lymphoblastic Leukemia

Marino Clavio Department of Haematology and Oncology University of Genoa Italy
,
Ivana Pierri Department of Haematology and Oncology University of Genoa Italy
,
Claudia Venturino Department of Haematology and Oncology University of Genoa Italy
,
Alberto Garrone Department of Haematology and Oncology University of Genoa Italy
,
Letizia Canepa Department of Haematology and Oncology University of Genoa Italy
,
Maurizio Miglino Department of Haematology and Oncology University of Genoa Italy
,
Riccardo Varaldo Department of Haematology and Oncology University of Genoa Italy
,
Filippo Ballerini Department of Haematology and Oncology University of Genoa Italy
,
Gian Luca Michelis Department of Haematology and Oncology University of Genoa Italy
,
Manuela Balocco Department of Haematology and Oncology University of Genoa Italy
,
Nabila Abdall Department of Haematology and Oncology University of Genoa Italy
,
Simona Gatto Department of Haematology and Oncology University of Genoa Italy
&
Marco Gobbi Department of Haematology and Oncology University of Genoa Italy
 show all
Pages 2527-2530 | Published online: 01 Jul 2009

References

  • Plunkett, W., Gandhi, V., Huang, P., Robertson, L.E., Yang, L.Y., et al. (1993) "Fludarabine:Pharmacolcinetics, mechanisms of action, and rationales for combination therapies", Sem. Oncol., 20, 2–12.
  • Estey, E., Plunkett, W., Gandhi, V., Beth Rios, M., Kantarjian, H. and Keating, M.J. (1993) "Fludarabine and Arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukaemia", Leuk. Lymphoma, 9, 343–350.
  • Visani, G., Tosi, P., Zinzani, P.L., Manfroi, S., Ottaviani, E., Cenacchi, A., etal. (1996) "FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects", Eur. J. Haematol., 56, 308–312.
  • Todeschini, G., Tecchio, C., Meneghini, V., Pizzolo, G., Veneri, D., Zanotti, R., et al. (1998) "Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin", Leukemia, 12, 144–149.
  • Michieli, M., Damiani, D., Ermacora, A., Masolini, P., Michelutti, A., Michelutti, T., et al. (1999) "Liposomal-encapsulated daunor-ubicin for Pgp-related multidrug resistance", Br. J. Haematol., 106, 92–99.
  • Ermacora, A., Michieli, M., Pea, F., Visani, G., Bucalossi, A. and Russo, D. (2000) "Liposome encapsulated daunorubicin (Daunox-ome) for acute leukemia", Haematologica, 85, 324–325.
  • Pierri, I., Miglino, M., Gatto, S., Venturino, C., Quintino, S., Beltrami, G., et al. (2000) "Combination of liposomal daunorubicin (Daunoxome), fludarabine and cytarabine as salvage therapy in relapsed and refractory acute leukemia", Blood, 96\(suppl 2), 215b.
  • Russo, D., Piccaluga, P.P., Michieli, M., Michelutti, T., Visani, G., Gugliotta, L., et al. (2002) "Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia", Ann. Haematol., 81, 462 — 466.
  • Cortes, J., Estey, E., O'Brien, S., Giles, F., Shen, Y., Koller, C., et al. (2001) "High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia", Cancer, 92, 7–14.
  • Krishnan, B., Hughes, D., Ethall, M., Potter, M., Mehta, A. and Grant Prentice, H. (2002) "Salvage chemotherapy with fludarabine, cytosine arabinoside, daunoxome and G CSF (FLAG X) in heavily pretreated children and adults with relapsed refractory lymphopro-liferative malignances. A single center experience", Blood, 100 (suppl 1), 560 a.
  • Kern, W., Schleyer, E., Braess, J., Wittmer, E., Ohnesorge, J., Unterhalt, M., et al. (2001) "Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias", Ann. Hematol., 80, 334–339.
  • Baccarani, M., Russo, D., Fanin, R. and Michieli, M. (2000) "Liposomal daunorubicin (Daunoxome) in the treatment of acute lymphocytic leukemia (ALL)", Blood, 96 (suppl 1), 720a, abtr. 3110.
  • Offidani, M., Corvatta, L., Centurioni, R., Leoni, F., Malerba, L., Mele, A., et al. (2003) "High dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lympho-blastic leukemia", Hematol. J., 4, 47–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.